Search reports.
Sclerotherapy Market Size, Share, and Industry Report [2030]
Get free sample report Request for Customiztion Buy Now

Sclerotherapy Market Size, Share, and Industry Report [2030]

Segments - Sclerotherapy Market by Agents (Detergents, Chemical Irritants, and Osmotic Agents), Types (Ultrasound Sclerotherapy, Liquid Sclerotherapy, and Foam Sclerotherapy), Applications Types (Venous Disease, Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease, Systemic Diseases), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2021-2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-467 | 4.4 Rating | 66 Reviews | 148 Pages | Format : PDF Excel PPT

Report Description


The global sclerotherapy market size was valued at USD 848.8 million in 2019 and is anticipated to grow at a CAGR of 5.6% from 2021 to 2028. Growing geriatric population, rising incidence of varicose veins, technological advancements pertaining to venous diseases, and growing demand for minimally invasive procedures are driving the market. Introduction of ultrasound-guided sclerotherapy and foam sclerotherapy has enabled practitioners to carry out these procedures in the underlying veins with precision and care.

Sclerotherapy is a minimally invasive procedure used for the treatment of spider veins or varicose veins and involves injecting the veins with sclerosing agents like detergents, chemicals, and osmotic agents. It causes shrinking of the veins and reduces the damage.

Global Sclerotherapy Market Outlook

  • Growing prevalence of thrombotic disorders leads to stroke or mesenteric ischemia, which drives the sclerotherapy market.
  • Recent advancements in cardiology such as revascularization and cardiogenic shock is likely to boost the sclerotherapy market.
  • Rising incidence of varicose veins drives the sclerotherapy market.
  • Complications in dermatological procedures such as bleeding and infection increases pain and discomfort and delays the healing process. This factor is likely to hamper the growth of the sclerotherapy market.
  • Treatment may cause matting, scarring, and allergic reactions in some patients, which might hinder the market growth.
  • Advent of advanced treatment options for varicose veins such as endovenous laser ablation, radiofrequency ablation, conventional operation, and subfascial endoscopic perforator surgery are expected to hinder the market growth.
  • Technical advancement in the field of sclerotherapy such as cryotherapy, which delivers cold air into the skin leading to a pain-free process, acts as an opportunity for the sclerotherapy market.

Scope of Sclerotherapy Market Report

The report on acupuncture needles market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Sclerotherapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018-2019

Forecast Period

2021-2028

Segmentation

Agents (Detergents, Chemical Irritants, and Osmotic Agents), Types (Ultrasound Sclerotherapy, Liquid Sclerotherapy, and Foam Sclerotherapy), Applications (Venous Disease, Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease, Systemic Diseases)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players

Boston Scientific Corporation, Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, TIANYU CHANG’AN GROUP, and AngioDynamics.

Sclerotherapy Market Segment Insights:

Global Sclerotherapy Market Taxonomy

Detergents Segment held a substantial market share during the forecast period

Based on agents, the sclerotherapy market is fragmented into detergents, chemical irritants, and osmotic agents. The detergents segment held a substantial market share of 42.0% in 2019 and is expected to witness a high CAGR during the forecast period. Detergents sclerosing agents are used to treat spider telangiectasias in various concentrations ranging from 0.05% to 0.5%. Detergents work by a mechanism known as protein theft denaturation, which causes endothelial damage or desquamation of endothelial cells in plaques through interference with cell surface lipids. Common types of detergents are Sodium Morrhuate (SM), Ethanolamine Oleate (EO), Sodium Tetradecyl Sulphate (Sotradecol), Polidocanol, and Scleremo.

Liquid Sclerotherapy is Expected to Occupy a Significant Share over the Forecast Period

On the basis of types, the sclerotherapy market is segmented into ultrasound sclerotherapy, liquid sclerotherapy, and foam sclerotherapy. The liquid sclerotherapy segment held a high market share of 38.0% in 2019 and is anticipated to witness a significant CAGR during the forecast period. Foam sclerotherapy is based on the air-block technique, wherein a small bubble of air is injected into the target vessel and the sclerosant is injected in the center of the bubble.

A foam with detergent sclerosants allows efficient sclerosant effect by increasing both contact area and dwell time and minimizing the admixture of sclerosant and blood. Increasing efficiency allows low sclerosants doses. Ultrasound-guided foam sclerotherapy is an upcoming therapy, which allows doctors to monitor the effect of each injection while ensuring the safety of all adjacent structures. It is effective as compared to a liquid therapy.

North America is Expected to Dominate the Sclerotherapy Myomectomy Market Over the Forecast Period

On the basis of regions, the sclerotherapy market is split into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is dominating the market and accounts for a revenue share of 46.1% in 2019. The market in North America is expected to witness a significant CAGR during the forecast period, due to increasing R&D investments and presence of global players. As per the Society of Vascular Surgery, more than 33.0% of women and about 17.0% of men consulted a doctor for telangiectasias and varicose veins in industrialized countries, affecting up to 35.0% of people in the US and Europe.

Global Sclerotherapy Market Region

Segments

By Agents

  • Detergents
  • Chemical Irritants
  • Osmotic Agents

By Types

  • Ultrasound Sclerotherapy
  • Liquid Sclerotherapy
  • Foam Sclerotherapy

By Application type

  • Venous Disease
  • Gastrointestinal Bleeding
  • Bronchopleural Fistula
  • Cystic Disease
  • Systemic Diseases

By Regions

  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East & Africa

Key Players

Competitive Landscape

Key players in the sclerotherapy market include Boston Scientific Corporation, Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, TIANYU CHANG’AN GROUP, and AngioDynamics. For instance, in March 2016, Merz Pharma and AngioDynamics, which produce innovative and minimally invasive medical devices for vascular access, surgery, and peripheral vascular disease, signed an agreement.

Global Sclerotherapy Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sclerotherapy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Sclerotherapy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Sclerotherapy Market - Supply Chain
  4.5. Global Sclerotherapy Market Forecast
     4.5.1. Sclerotherapy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Sclerotherapy Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Sclerotherapy Market Absolute $ Opportunity
5. Global Sclerotherapy Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Sclerotherapy Market Size and Volume Forecast by Types
     5.3.1. Ultrasound Sclerotherapy
     5.3.2. Liquid Sclerotherapy
     5.3.3. Foam Sclerotherapy
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Sclerotherapy Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Sclerotherapy Market Size and Volume Forecast by Applications
     6.3.1. Venous Disease
     6.3.2. Gastrointestinal Bleeding
     6.3.3. Bronchopleural Fistula
     6.3.4. Cystic Disease
     6.3.5. Systemic Diseases
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Sclerotherapy Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Sclerotherapy Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Sclerotherapy Demand Share Forecast, 2019-2026
8. North America Sclerotherapy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Sclerotherapy Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Sclerotherapy Market Size and Volume Forecast by Types
     8.4.1. Ultrasound Sclerotherapy
     8.4.2. Liquid Sclerotherapy
     8.4.3. Foam Sclerotherapy
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Sclerotherapy Market Size and Volume Forecast by Applications
     8.7.1. Venous Disease
     8.7.2. Gastrointestinal Bleeding
     8.7.3. Bronchopleural Fistula
     8.7.4. Cystic Disease
     8.7.5. Systemic Diseases
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Sclerotherapy Demand Share Forecast, 2019-2026
9. Latin America Sclerotherapy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Sclerotherapy Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Sclerotherapy Market Size and Volume Forecast by Types
     9.4.1. Ultrasound Sclerotherapy
     9.4.2. Liquid Sclerotherapy
     9.4.3. Foam Sclerotherapy
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Sclerotherapy Market Size and Volume Forecast by Applications
     9.7.1. Venous Disease
     9.7.2. Gastrointestinal Bleeding
     9.7.3. Bronchopleural Fistula
     9.7.4. Cystic Disease
     9.7.5. Systemic Diseases
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Sclerotherapy Demand Share Forecast, 2019-2026
10. Europe Sclerotherapy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Sclerotherapy Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Sclerotherapy Market Size and Volume Forecast by Types
     10.4.1. Ultrasound Sclerotherapy
     10.4.2. Liquid Sclerotherapy
     10.4.3. Foam Sclerotherapy
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Sclerotherapy Market Size and Volume Forecast by Applications
     10.7.1. Venous Disease
     10.7.2. Gastrointestinal Bleeding
     10.7.3. Bronchopleural Fistula
     10.7.4. Cystic Disease
     10.7.5. Systemic Diseases
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Sclerotherapy Demand Share Forecast, 2019-2026
11. Asia Pacific Sclerotherapy Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Sclerotherapy Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Sclerotherapy Market Size and Volume Forecast by Types
     11.4.1. Ultrasound Sclerotherapy
     11.4.2. Liquid Sclerotherapy
     11.4.3. Foam Sclerotherapy
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Sclerotherapy Market Size and Volume Forecast by Applications
     11.7.1. Venous Disease
     11.7.2. Gastrointestinal Bleeding
     11.7.3. Bronchopleural Fistula
     11.7.4. Cystic Disease
     11.7.5. Systemic Diseases
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Sclerotherapy Demand Share Forecast, 2019-2026
12. Middle East & Africa Sclerotherapy Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Sclerotherapy Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Sclerotherapy Market Size and Volume Forecast by Types
     12.4.1. Ultrasound Sclerotherapy
     12.4.2. Liquid Sclerotherapy
     12.4.3. Foam Sclerotherapy
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Sclerotherapy Market Size and Volume Forecast by Applications
     12.7.1. Venous Disease
     12.7.2. Gastrointestinal Bleeding
     12.7.3. Bronchopleural Fistula
     12.7.4. Cystic Disease
     12.7.5. Systemic Diseases
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Sclerotherapy Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Sclerotherapy Market: Market Share Analysis
  13.2. Sclerotherapy Distributors and Customers
  13.3. Sclerotherapy Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Boston Scientific Corporation
     13.4.2. Chemische Fabrik Kreussler & Co. GmbH
     13.4.3. LGM Pharma
     13.4.4. TIANYU CHANG’AN GROUP
     13.4.5. AngioDynamics

Methodology

Our Clients

Nestle SA
General Mills
The John Holland Group
Dassault Aviation
General Electric
Honda Motor Co. Ltd.
Pfizer
FedEx Logistics